Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.78)
# 768
Out of 5,182 analysts
491
Total ratings
41.99%
Success rate
10.25%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EDAP EDAP TMS | Maintains: Buy | $14 → $10 | $3.29 | +203.95% | 15 | Apr 9, 2026 | |
| RNXT RenovoRx | Reiterates: Buy | $3 | $0.97 | +210.53% | 4 | Apr 8, 2026 | |
| IPHA Innate Pharma | Reiterates: Buy | $5 | $1.42 | +252.11% | 19 | Apr 7, 2026 | |
| PGEN Precigen | Maintains: Buy | $9 → $10 | $4.16 | +140.67% | 15 | Mar 26, 2026 | |
| CORT Corcept Therapeutics | Maintains: Buy | $67 → $60 | $41.92 | +43.13% | 30 | Mar 25, 2026 | |
| OCGN Ocugen | Maintains: Buy | $7 → $10 | $1.76 | +468.18% | 23 | Mar 25, 2026 | |
| PYXS Pyxis Oncology | Reiterates: Buy | $7 | $1.71 | +310.56% | 12 | Mar 24, 2026 | |
| MIRM Mirum Pharmaceuticals | Reiterates: Buy | $130 | $95.21 | +36.55% | 6 | Mar 23, 2026 | |
| ETON Eton Pharmaceuticals | Maintains: Buy | $37 → $52 | $26.35 | +97.34% | 10 | Mar 20, 2026 | |
| LFWD Lifeward | Maintains: Buy | $4.5 → $10 | $6.52 | +53.49% | 9 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.39 | +331.65% | 16 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.74 | +130.55% | 16 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $130 | $89.72 | +44.90% | 9 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.04 | +296.04% | 15 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $64 | $33.72 | +89.80% | 19 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $18 | $6.07 | +196.54% | 14 | Jan 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $10.05 | +198.51% | 16 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.58 | +55.04% | 1 | Jan 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.90 | - | 17 | Dec 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $2.99 | +168.01% | 15 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $70 → $45 | $14.99 | +200.20% | 14 | Dec 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $36 | $17.96 | +100.45% | 20 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.70 | +1,079.94% | 4 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $155 | $102.82 | +50.75% | 5 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $94 | $117.04 | -19.69% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $15.46 | +106.99% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $6.04 | +115.23% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.10 | +21.95% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $7,500 | $2.92 | +256,749.32% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $6.63 | +231.83% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.88 | +240.75% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.38 | +2,793.21% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.17 | +591.24% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.65 | +360.12% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $0.74 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.74 | +101.15% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $4.95 | +567.34% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $5.49 | +2,176.87% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.89 | +183.14% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $0.62 | +3,112.34% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $8.01 | +12.36% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.97 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.24 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.31 | +1,808.40% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.80 | +31.58% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.81 | +4,178.07% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $4.47 | +347.43% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.60 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $15.11 | -60.29% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.18 | +1,171.19% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.32 | +520.30% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.90 | -12.80% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $0.83 | +1,692,151.90% | 1 | Mar 5, 2020 |
EDAP TMS
Apr 9, 2026
Maintains: Buy
Price Target: $14 → $10
Current: $3.29
Upside: +203.95%
RenovoRx
Apr 8, 2026
Reiterates: Buy
Price Target: $3
Current: $0.97
Upside: +210.53%
Innate Pharma
Apr 7, 2026
Reiterates: Buy
Price Target: $5
Current: $1.42
Upside: +252.11%
Precigen
Mar 26, 2026
Maintains: Buy
Price Target: $9 → $10
Current: $4.16
Upside: +140.67%
Corcept Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $67 → $60
Current: $41.92
Upside: +43.13%
Ocugen
Mar 25, 2026
Maintains: Buy
Price Target: $7 → $10
Current: $1.76
Upside: +468.18%
Pyxis Oncology
Mar 24, 2026
Reiterates: Buy
Price Target: $7
Current: $1.71
Upside: +310.56%
Mirum Pharmaceuticals
Mar 23, 2026
Reiterates: Buy
Price Target: $130
Current: $95.21
Upside: +36.55%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $37 → $52
Current: $26.35
Upside: +97.34%
Lifeward
Mar 19, 2026
Maintains: Buy
Price Target: $4.5 → $10
Current: $6.52
Upside: +53.49%
Mar 13, 2026
Reiterates: Buy
Price Target: $6
Current: $1.39
Upside: +331.65%
Mar 10, 2026
Reiterates: Buy
Price Target: $4
Current: $1.74
Upside: +130.55%
Mar 9, 2026
Maintains: Buy
Price Target: $47 → $130
Current: $89.72
Upside: +44.90%
Mar 9, 2026
Reiterates: Buy
Price Target: $16
Current: $4.04
Upside: +296.04%
Feb 27, 2026
Maintains: Buy
Price Target: $60 → $64
Current: $33.72
Upside: +89.80%
Jan 26, 2026
Maintains: Buy
Price Target: $25 → $18
Current: $6.07
Upside: +196.54%
Jan 9, 2026
Reiterates: Buy
Price Target: $30
Current: $10.05
Upside: +198.51%
Jan 7, 2026
Initiates: Buy
Price Target: $4
Current: $2.58
Upside: +55.04%
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.90
Upside: -
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $2.99
Upside: +168.01%
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $14.99
Upside: +200.20%
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $17.96
Upside: +100.45%
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $1.70
Upside: +1,079.94%
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $102.82
Upside: +50.75%
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $117.04
Upside: -19.69%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $15.46
Upside: +106.99%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $6.04
Upside: +115.23%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.10
Upside: +21.95%
Nov 4, 2025
Assumes: Buy
Price Target: $7,500
Current: $2.92
Upside: +256,749.32%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $6.63
Upside: +231.83%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.88
Upside: +240.75%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $0.38
Upside: +2,793.21%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.17
Upside: +591.24%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.65
Upside: +360.12%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $0.74
Upside: -
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.74
Upside: +101.15%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $4.95
Upside: +567.34%
Nov 21, 2024
Reiterates: Buy
Price Target: $125
Current: $5.49
Upside: +2,176.87%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $3.89
Upside: +183.14%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $0.62
Upside: +3,112.34%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $8.01
Upside: +12.36%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.97
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $2.24
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.31
Upside: +1,808.40%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $3.80
Upside: +31.58%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.81
Upside: +4,178.07%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $4.47
Upside: +347.43%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $18.60
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $15.11
Upside: -60.29%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.18
Upside: +1,171.19%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.32
Upside: +520.30%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.90
Upside: -12.80%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $0.83
Upside: +1,692,151.90%